Stocks
Atara Biotherapeutics (ATRA) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -295.7 | -309.1 | -340.5 | -330.8 | -264.4 | -212.9 | ||
| Changes by years, y/y, % | +25% | +5% | +10% | -3% | -20% | +2.2% | |||
Atara Biotherapeutics. EBITDA US GAAP, bln rub
Atara Biotherapeutics. EBITDA US GAAP, changes, %
Atara Biotherapeutics. EBITDA US GAAP, sum by quarters, bln rub
Atara Biotherapeutics (ATRA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -75.0 | -68.5 | -67.2 | -52.1 | -25.1 | -212.9 | |
| Changes by years, y/y, % | -13% | -15% | -19% | -31% | -67% | |||
| Changes by quarters, q/q, % | -1% | -9% | -2% | -23% | -52% | |||
